A process for the preparation of 2,2-disubstituted pyrroles

Details for Australian Patent Application No. 2005236066 (hide)

Owner Merck & Co., Inc.

Inventors Javadi, Gary; Miller, Ross A.; Maeda, Kenji; Szumigala, Ronald H.; Karady, Sandor

Agent Spruson & Ferguson

Pub. Number AU-A-2005236066

PCT Pub. Number WO2005/102996

Priority 60/563,583 19.04.04 US

Filing date 15 April 2005

Wipo publication date 3 November 2005

International Classifications

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 263/04 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 263/52 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/102996 Priority application(s): WO2005/102996

14 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005236067-Pattern recognition method for diagnosis of systemic autoimmune diseases

2005236064-RNAI-based target identification and validation